Gossamer Bio (GOSS) Payables (2018 - 2026)
Gossamer Bio (GOSS) recorded Payables of $5.95 million in Q2 2026, up 217.2% from $1.88 million a year earlier but down 45.0% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Gossamer Bio reported Payables of $5.96 million, up 157.0% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Across earlier years, Payables came in at $2.32 million in FY2024 (-58.0%), $5.53 million in FY2023 (+278.8%), $1.46 million in FY2022 (-55.0%) and $3.24 million in FY2021 (-56.8%).
- Quarterly Payables has ranged from $363,000 in Q3 2022 to $10.82 million in Q1 2026 over the past five years.
- On a year-over-year basis, Payables has increased for three consecutive quarters, with growth averaging 91.4% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 361.3% in Q1 2023, against a decline of 69.4% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.82 million (Q1 2026), $5.96 million (Q4 2025) and $1.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.43 Bn | 1,102.02 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 615.31 Bn | 533.83 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 505.93 Bn | 479.05 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.28 Bn | 191.68 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.31 Bn | 164.51 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.69 Bn | 117.33 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Gossamer Bio | 40.29 Mn | -433.10 Mn | - | 5.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.95 Mn |
| Mar 31, 2026 | 10.82 Mn |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.88 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 363,000.00 |
| Jun 30, 2022 | 3.91 Mn |
| Mar 31, 2022 | 592,000.00 |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 1.19 Mn |
API Access
Gossamer Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();